Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients Treated for Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT06834438
What this trial is testing

Gene Therapy for Neurofibromatosis Type 2 (NF2) with ST002

Who this might be right for
NF2 Deficiency
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 9
Testing effectiveness (Phase 2)Study completedNCT01088984
What this trial is testing

Study of Bendamustine Hydrochloride for the Treatment of Pediatric Patients With Relapsed or Refractory Acute Leukemia

Who this might be right for
Leukemia
Teva Branded Pharmaceutical Products R&D, Inc. 43
Not applicableLooking for participantsNCT05787834
What this trial is testing

Home-based Respiratory Muscle Training for Minimizing Side Effects in Patients Undergoing Treatment for Cancer

Who this might be right for
Breast CarcinomaHead and Neck CancerLung Cancer
Roswell Park Cancer Institute 130
Testing effectiveness (Phase 2)Active Not RecruitingNCT05630209
What this trial is testing

Blood Brain Barrier (BBB) Disruption Using Exablate Focused Ultrasound With Doxorubicin for Treatment of Pediatric Diffuse Intrinsic Pontine Gliomas (DIPG)

Who this might be right for
Brain Tumor
InSightec 10
Not applicableStudy completedNCT03751384
What this trial is testing

Improvement of Compliance for High Doses of EPA Amongst Patients With Colorectal Cancer

Who this might be right for
ComplianceAbdominal Cancer
University of Copenhagen 41
Testing effectiveness (Phase 2)Study completedNCT00216866
What this trial is testing

The Catheter Study: Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombosis

Who this might be right for
Embolism and Thrombosis
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 70
Testing effectiveness (Phase 2)Ended earlyNCT00849251
What this trial is testing

Pegylated Liposomal Doxorubicin Hydrochloride, Bortezomib, Cyclophosphamide, and Dexamethasone in Treating Patients With Multiple Myeloma

Who this might be right for
Refractory Multiple MyelomaStage I Multiple MyelomaStage II Multiple Myeloma+1 more
University of Washington 31
Large-scale testing (Phase 3)Study completedNCT01460030
What this trial is testing

An Intra-individual Titration Study of KRN1493 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Intractable Primary Hyperparathyroidism

Who this might be right for
Parathyroid CarcinomaHypercalcemiaPrimary Hyperparathyroidism
Kyowa Kirin Co., Ltd.
Not applicableLooking for participantsNCT07064330
What this trial is testing

Next-gen Flow Cytometry to Find Immune Profiles, Treatment Response, and Toxicity Markers in Skin Cancer Patients Treated With Cemiplimab.

Who this might be right for
Cutaneous Squamous Cell Carcinoma (CSCC)
Instituto de Investigación Biomédica de Salamanca 30
Very early researchUnknownNCT03661554
What this trial is testing

BCMA Nano Antibody CAR-T Cells for Patients With Refractory and Relapsed Multiple Myeloma

Who this might be right for
Relapsed and Refractory Multiple Myeloma
The Pregene (ShenZhen) Biotechnology Company, Ltd. 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT03979131
What this trial is testing

Phase II Study of Avelumab Plus Chemotherapy in the Peri-operative Treatment for Patients With Resectable Gastric Cancer (GC) or Gastroesophageal Junction Cancer (GEJC)

Who this might be right for
Gastroesophageal Junction AdenocarcinomaStomach Neoplasms
Vall d'Hebron Institute of Oncology 40
Testing effectiveness (Phase 2)UnknownNCT05970302
What this trial is testing

XELOX +Bev +Tislelizumab for First-line Treatment of MSS/pMMR RAS-mutated mCRC

Who this might be right for
TislelizumabBevacizumabOxaliplatin+5 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 52
Testing effectiveness (Phase 2)Study completedNCT00003312
What this trial is testing

Brachytherapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 95
Testing effectiveness (Phase 2)Study completedNCT00075881
What this trial is testing

Bortezomib in Treating Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma
National Cancer Institute (NCI) 44
Early research (Phase 1)Looking for participantsNCT06399419
What this trial is testing

CBM588 Capsules in Combination With Nivolumab and Ipilimumab for the Treatment of Advanced Stage Kidney Cancer

Who this might be right for
Advanced Clear Cell Renal Cell CarcinomaAdvanced Renal Cell CarcinomaAdvanced Sarcomatoid Renal Cell Carcinoma+5 more
Osel, Inc. 28
Not applicableActive Not RecruitingNCT05775757
What this trial is testing

SMC Radiation Oncology Breast Cancer Cohort Study

Who this might be right for
Radiotherapy Side Effect
Samsung Medical Center 500
Testing effectiveness (Phase 2)Looking for participantsNCT05231122
What this trial is testing

Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer

Who this might be right for
Ovarian Clear Cell AdenocarcinomaPlatinum-Sensitive Ovarian CarcinomaRecurrent Endometrial Serous Adenocarcinoma+12 more
Roswell Park Cancer Institute 80
Testing effectiveness (Phase 2)Looking for participantsNCT04776395
What this trial is testing

Iberdomide Alone or in Combination With Dexamethasone for the Treatment of Intermediate- or High-Risk Smoldering Multiple Myeloma

Who this might be right for
Smoldering Plasma Cell Myeloma
Emory University 68
Testing effectiveness (Phase 2)Study completedNCT00017212
What this trial is testing

DX-8951f in Treating Patients With Metastatic Stomach Cancer

Who this might be right for
Esophageal CancerGastric Cancer
Daiichi Sankyo
Testing effectiveness (Phase 2)UnknownNCT03502629
What this trial is testing

Clinical Trial in Chinese Patients of Relapsed and Refractory Peripheral T Cell Lymphoma (GB226)

Who this might be right for
Peripheral T Cell Lymphoma
Genor Biopharma Co., Ltd. 86
Next Page